Olema Pharmaceuticals (OLMA) Interest Expenses (2020)
Olema Pharmaceuticals (OLMA) reported Interest Expenses of $653000.0 for Q1 2020.
Olema Pharmaceuticals (OLMA) Interest Expenses (2020) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 1 years of Interest Expenses data on file, last reported at $653000.0 in Q1 2020.
- Interest Expenses for Q1 2020 came in at $653000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $653000.0 (changed N/A YoY), and the FY2020 annual result was $653000.0, changed N/A from the prior year.
- Interest Expenses was little changed at $653000.0 in Q1 2020 per OLMA's latest filing.
- Over five years, Interest Expenses peaked at $653000.0 in Q1 2020 and troughed at $653000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -5.58 Mn |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 653,000.00 |
| Mar 31, 2020 | 653,000.00 |